% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, AŞ Message Board

  • calaggie71 calaggie71 Sep 4, 2013 2:25 PM Flag



    Astex Pharmaceuticals Inc. (ASTX:US), the maker of an experimental leukemia therapy, jumped the most in 17 years after a report that Japanese drugmaker Otsuka Holdings Co. (4578) has decided to buy the biotechnology company for an estimated $900 million (90 billion yen).

    Astex rose 29 percent to $8.59 at 1:44 p.m. New York time, giving the Dublin, California-based company a market value of $817 million. Astex earlier climbed as much as 41 percent, its largest intraday increase since 1996.

    Japan’s Nikkei newspaper reported today that Tokyo-based Otsuka will buy Astex to increase its stable of cancer drugs. Astex reported on Aug. 28 that its experimental treatment SGI-110 had positive results in a mid-stage clinical trial of myeloid leukemia patients.

    Timothy Enns, a spokesman for Astex, didn’t immediately repond to an e-mail or answer a phone call seeking comment on the report.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies